Every material Form 8-K NATURAL HEALTH TRENDS CORP has filed with the SEC since May 07, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Natural Health Trends reported third-quarter 2026 results, with revenue of $7.6 million, down 20% from $9.5 million a year earlier and flat with the second quarter. The net loss narrowed to $232,000, or $0.03 per diluted share, from $431,000 a year earlier, but nine-month net loss widened to $837,000 from $294,000, and the company said conditions remain challenging.
Q3 2026 revenue was $7.6 million, flat with Q2 2026 and down 20% from $9.5 million in Q3 2025.
Q3 2026 operating loss was $277,000, down from $643,000 in Q2 2026 and $495,000 in Q3 2025.
Year-to-date revenue was $24.4 million, down 19%, and the nine-month net loss was $837,000, or $0.09 per diluted share, versus $294,000 a year earlier.
The Board authorized additional share repurchases, with $15.8 million available; cash and marketable securities were $17.6 million at September 30, 2026.
Natural Health Trends reported second-quarter 2026 revenue of $7.6 million, down 23% from $9.8 million a year earlier, and a net loss of $451,000 ($0.05 per diluted share), compared with net income of $15,000 in the second quarter of 2025. The company cited cautious consumer spending in China, regulatory uncertainty, and conduct by certain members that violated Hong Kong policies, which it said adversely affected revenue and operating results. The Board also authorized resuming share repurchases, with $15.9 million remaining under the program.
Q2 2026 revenue of $7.6 million, down 23% from $9.8 million in Q2 2025; operating loss of $643,000 versus $333,000 a year earlier
Net loss of $451,000, or $0.05 per diluted share, versus net income of $15,000 in Q2 2025
Active Members were 26,000 at June 30, 2026, down from 29,260 at June 30, 2025
Board authorized resuming stock repurchases with $15.9 million remaining; cash and marketable securities were $18.6 million at June 30, 2026
At its May 7, 2026 annual meeting, Natural Health Trends stockholders approved the 2026 Equity Incentive Plan, which allows up to 1,100,000 shares of common stock to be issued in awards to employees, officers, directors, contractors, consultants and advisors. Four directors were elected, and stockholders ratified CBIZ CPAs P.C. as the independent auditor for fiscal 2026.
The 2026 Plan permits up to 1,100,000 common shares in awards, subject to adjustment; the board adopted it on March 19, 2026.
Randall A. Mason, Chris T. Sharng, Ellen Sun and Ching C. Wong were elected directors; Ching C. Wong received 2,203,458 votes for and 778,843 withheld.
Shareholders ratified CBIZ CPAs P.C. with 4,851,540 votes for, 115,114 against and 16,189 abstentions.
Shares represented were 4,982,843, or 58.1% of the 8,577,848 entitled to vote.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every NATURAL HEALTH TRENDS CORP filing is on SEC EDGAR ↗. 8-K briefs of other companies →